|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�ƺְ� |
|
�����Ʒ�(רҵ) |
|
ҩ���Ʒ� |
| ��������������� | |
|
���� |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
�ƺְߵ�������״
����, ������
���ϴ�ѧҽѧԺ���ĸ���ҽԺ�������к�ʮ�ֻ�ҽԺ��ҽ��
�ƺְ��Ƕ��������Ů���沿��ɫ�س�����Ƥ����,�����Ʒ�����һ,�����Ρ����η�,����ҽҩ����ҩ������������Ƶȡ�������Ч�����������Լ����ܳ��ֵIJ�����Ӧ,һֱ��Ƥ�����ٴ�ҽʦ�����ٵļ������⡣����ȥɫ�ػ���ɫ�Ƽ��������ƻƺְ���õ���Ч������
[2] Tantcheva LP, Stoeva ES, Galabov AS, et al. Effect of vitamin E and vitamin C combination on experimental influenza virus infection. Methods Find Exp Clin Pharmacol, 2003, 25:259-264.
[3] Ni Z, Mu Y, Gulati O. Treatment of melasma with Pycnogenol. Phytother Res, 2002, 16:567-571.
[4] Kubo I, Kinst-Hori I, Chaudhuri SK, et al. Flavonols from Heterotheca inuloides:tyrosinase inhibitory activity and structural criteria. Bioorg Med Chem, 2000, 8:1749-1755.
[5] Kim YM, Yun J, Lee CK, et al. Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J Biol Chem, 2002, 277:16340-16344.
[6] Burkitt M J, Duncan J. Effects of trans-resveratrol on copper-depen dent hydroxyl-radical formation and DNA damage:evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mecha nism of action. Arch Biochem Biophys, 2000, 381:253-263.
[7] Yamakoshi J, Sano A, Tokutake S, et al. Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma. Phy tother Res, 2004, 18:895-899.
[8] Bagchi D, Garg A, Krohn RL, et al. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol, 1997, 95:179-189.
[9] Perez-Bernal A, Munoz-Perez MA, Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol, 2000, 1:261-268.
[10] Kligman DE, Sadiq I, Pagnoni A, et al. High-strength tretinoin:a method for rapid retinization of facial skin. J Am Acad Dermatol, 1998, 39:S93-S97.
[11] Espinal-Perez LE, Moncada B, Castanedo-Cazares JP. A doubleblind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol, 2004, 43:604-607.
[12] Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg, 1999, 25:282-284.
[13] Lirm JT, Tham SN. Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg, 1997, 23:177-179.
[14] Menter A. Rationale for the use of topical corticosteroids in melas ma. J Drugs Dermatol, 2004, 3:169-174.
[15] Kar HK. Efficacy of beta-carotene topical application in melasma:An open clinical trial. Indian J Dermatol Venereol Leprol, 2002, 68:320-322
[16] Lee MH, Kim HJ, Ha DJ, et al. Therapeutic effect of topical application of linoleic acid and lincomycin in combination with betamethasone valerate in melasma patients. J Korean Med Sci, 2002,
[17] :518-523.17.Raulin C, Schonermark MP, Greve B, et al. Q-switched ruby laser treatment of tattoos and benign pigmented skin lesions:a critical review. Ann Plast Surg, 1998, 41:555-565.
[18] Manaloto RM, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg, 1999, 25:121-123.
[19] Sarkar R, Kaur C, Bhalla M, et al. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in darkskinned patients:a comparative study. Dermatol Surg, 2002, 28:828-832.
[20] Taylor SC, Torok H, Jones T, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis, 2003, 72:67-72.
[21] Rendon MI. Utilizing combination therapy to optimize melasma out comes. J Drugs Dermatol, 2004, 3(5 Suppl):S27-S34.